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Introduction
The marked difference in biopersistence and pathologi-
cal response between chrysotile and amphibole asbestos 
has been documented in studies from a range of sources 
(Bernstein  &  Hoskins,  2006).  This  study,  however,  is 
unique in that it has examined a commercial chrysotile 
product  that  was  used  as  a  joint  compound.  In  addi-
tion, the pathological response was quantified by com-
partment in the lung and translocation of fibers to and 
pathological response in the pleural cavity determined. 
The  interim  results  from  the  study  were  presented  in 
Bernstein  et  al.  (2010).  This  paper  presents  the  final 
results from the study, including the details of the mea-
surements in the pleural cavity.
This  study  was  specifically  designed  to  evaluate  the 
pathological response and fiber distribution within the lung 
and pleural cavity. The difficulty of sampling the thin plu-
ral surfaces has been well documented. As summarized 
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The marked difference in biopersistence and pathological response between chrysotile and amphibole asbestos 
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by Zocchi (2002) , direct in vitro measurements of the 
biophysical properties of the pleura appear unreliable, 
because the mesothelium is very labile (Fentie et al., 1986; 
Peng et al., 1994; Agostoni, 1998 ), and the procedures 
required to obtain specimens are likely to compromise it 
(Agostoni, 1998). In order to minimize pleural sampling 
artifacts, two independent methods were developed for 
examining the translocation of fibers to the pleural cav-
ity and any associated inflammatory response following 
exposure either to the chrysotile and sanded particulate 
(CSP) or to the amosite asbestos. These methods included 
examination of the diaphragm as a parietal pleural tis-
sue and the in situ examination of the lungs and pleural 
space obtained from freeze-substituted tissue in deep-
frozen rats.
The diaphragm was chosen as the parietal pleural tis-
sue for examination because it can be quickly removed 
at necropsy with minimal alteration of the visceral lung 
surface. An area which included an important lymphatic 
drainage  site  (stomata)  on  the  diaphragmatic  surface 
was selected for examination of possible inflammatory 
response  using  scanning  electron  microscopy  (SEM) 
and for the presence of fibers using confocal microscopy 
(CM).
In order to examine the visceral pleura environment, 
including the subpleural lung, the visceral pleural itself, 
and the pleural space, a noninvasive method for deter-
mining  fiber  location,  size,  inflammatory,  and  fibrotic 
response  was  used  on  rats,  which  were  deep  frozen 
immediately after killing.
In this study, to simulate the exposures encountered 
during the use of the product, the joint compound was 
applied  and  then  dust  released  during  sanding  was 
collected.  Sanding  of  the  joint  compound  resulted  in 
concomitant exposure to both chrysotile fibers (inher-
ent  within  the  joint  compound)  and  joint  compound 
particles. However, few fibers >20 µm were present after 
sanding.  Consequently,  in  order  to  fulfill  the  require-
ments of the protocol on which the exposure design was 
based (EUR 18748 EN, 1999; ILSI, 2005) (>100 f/cc longer 
than 20 µm; this length category being related to patho-
genesis), chrysotile fibers were added to the sanded joint 
compound (CSP).
CSP sample characteristics
The  specification  and  preparation  of  the  Ready-mix 
used to produce the sanded material has been described 
previously (Brorby et al., 2008; Bernstein et al., 2010). 
Extensive characterization including comparison of the 
bivariate size distribution was performed to confirm that 
the chrysotile used in the recreated formulation in this 
study (JM 7RF3 from the Jeffrey Mine in Quebec, Canada) 
closely matched that from a historical sample of the joint 
compound (Brorby et al., 2008). No historical Ready-mix 
formulations specified use of amphibole asbestos at any 
time.
To  simulate  typical  usage  of  the  joint  compound, 
the recreated material was applied to pieces of drywall 
the ends of which were sealed with tape according to 
the instructions for the original material. The material 
was  allowed  to  dry  for  at  least  48 h  and  then  sanded. 
Individual boards were sanded for 20–30 min. Four differ-
ent boards were used to obtain a sufficient mass of mate-
rial for these studies. The sanded material was collected 
in a large Ziploc bag and the bag was sent to the Research 
and  Consulting  Company  Ltd.  (RCC;  currently  known 
as  Harlan  Laboratories  Ltd.),  Füllinsdorf,  Switzerland, 
where the inhalation exposures were performed.
Amosite used in this study was from the same batch as 
used in previous studies (Hesterberg et al., 1997, 1999a,b; 
McConnell et al., 1999; Rogers et al., 1999).
Materials and methods
All  studies  were  conducted  by  RCC  Ltd.  (Basel, 
Switzerland)  according  to  the  Swiss  Ordinance  relat-
ing to Good Laboratory Practice adopted 18 May 2005 
[RS  813.112.1].  This  Ordinance  is  based  on  the  OECD 
Principles of Good Laboratory Practice, as revised in 1997 
and adopted 26 November 1997 by the OECD Council [C 
(97)186/Final].
A pilot-study using both chrysotile alone and CSP was 
performed to assess the feasibility of a mixed exposure 
study. A few animals were exposed to each test material 
for 5 days and then examined for up to 3 days postexpo-
sure. The results, reported by Bernstein et al. (2008), con-
firmed the feasibility of performing this mixed exposure 
study. Detailed description of the fiber exposure methods 
is presented in Bernstein et al. (2008).
The methodology used in the fiber exposure and the 
in-life  phases  of  the  study  conforms  to  the  guideline 
issued by the European Commission (ECB/TM/26 rev.7, 
1999) with the following enhancements:
The  fiber  evaluation  was  performed  using  an  •	
Analytical  Scanning  Transmission  Electron 
Microscope  with  Energy  Dispersive  X-ray  analysis 
(ASTEM-EDS) using an accelerating voltage of 80 kV 
and a magnification of at least 10,000×.
The analytical part of the ISO 13794 method for the  •	
determination  of  asbestos  in  ambient  air  by  the 
indirect-transfer  transmission  electron  microscopy 
(TEM) procedure was used.
The stopping rules for fiber counting included spe- •	
cific rules for four different length categories as fol-
lows: 100 fibers with a length < 5 μm, 200 fibers with 
a length between 5 and 20 μm, and 100 fibers with a 
length > 20 μm and 100 particles.
Sample preparation
The JM 7RF3 grade 7 chrysotile sample was received 
by RCC Ltd. from Exponent, Inc. The fiber as received 
contained  fiber  bundles,  which  were  too  thick  to  be 
rat respirable. In order to separate the fiber bundles, 
the fiber was processed using a small-scale, table-top, 
Cyclotec 1093 Sample Mill (FOSS Tecator, Sweden). This CSP pleural transfer and pathological response  365
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is a low volume device, which opens the fiber bundles 
while obviating thermal degradation or contamination. 
Samples of a few milligrams of chrysotile were placed 
into the Cyclotec for a period of 1 min. This procedure 
was repeated three times for each sample to effectively 
open the bundles. No further processing was performed 
on the chrysotile. As presented in the results, the length 
distribution of the processed fibers in the aerosol was 
consistent  with  that  of  the  pre-Cyclotec  processed 
chrysotile sample.
Amosite used in this study was from the same batch as 
used in previous studies (Hesterberg et al., 1997, 1999a,b; 
McConnell et al., 1999; Rogers et al., 1999).
Animal exposure
Acclimation:  All  animals  were  acclimatized  to  the 
restraint tubes and the inhalation exposure conditions 
by sham dosing over a period of 4 days of ~ 1, 2, 4, and 6 h 
on each successive day, respectively.
Three groups of rats were exposed for 6 h per day for 
5 days to:
Group 1: Filtered air alone (negative control group). •	
Group 2: A fixed exposure level of well-characterized  •	
CSP.
Group 3: A fixed exposure level of well-characterized  •	
amosite asbestos fibers.
 Groups  of  93  weanling  (8-  to  10-week-old)  male 
rats  (HanRcc:  WIST(SPF),  Harlan  Laboratories 
Ltd.  Laboratory  Animal  Services,  4414  Füllinsdorf/
Switzerland) were exposed by inhalation in a flow-past 
nose-only exposure system for 6 h/day for a period of 5 
consecutive days either to CSP (group 2) or to amosite 
asbestos  (group  3).  This  system  was  derived  from 
Cannon et al. (1983) and is different from conventional 
nose-only exposure systems in that fresh fiber aerosol 
is supplied to each animal individually and exhaled air 
is immediately exhausted. Schematic diagrams of each 
exposure systems used in the study were presented in 
Bernstein et al. (2008). In the negative control group 
(group 1), 56 rats were exposed in a similar fashion to 
filtered air passed through an unloaded aerosol gen-
erator. In group 2, additional commercial grade 7RF3 
chrysotile (from the same batch used to reformulate 
the joint compound) was added to the sanded powder 
containing short fiber chrysotile to assure compliance 
with the fiber exposure specifications of the EC protocol 
(EUR 18748 EN., 1999). In groups 2 and 3, a fiber con-
centration higher than that required by the EC Protocol 
of 100 fibers with length L > 20 μm/cm3 was used in 
order to assure there was sufficient long fiber exposure. 
No amphibole (tremolite) fibers were detected in any of 
the analytical TEM with energy dispersive x-ray analy-
sis (EDS) examinations.
For  group  2  (CSP),  two  aerosols  were  generated 
using  individual  rotating  brush  aerosol  generators. 
A  fiber  aerosol  was  generated  from  chrysotile  fiber 
7RF3 and a separate dust/fiber aerosol was generated 
from sanded material. The chrysotile fiber aerosol was 
passed through a 500-ml Pyrex glass cyclone to assist 
in the elimination of fiber bundles. The sanded pow-
der aerosol was passed through a micronizing jet mill 
to reduce the particle size to be rat respirable. In-line 
63Ni charge neutralizers were used to reduce the elec-
trostatic charge to Boltzmann equilibrium. Following 
the charge neutralizers, the fiber and powder aerosols 
were mixed through a stainless steel Y-connection and 
then  delivered  directly  into  the  nose-only  flow-past 
exposure chamber.
For group 3, the aerosol of the amosite fiber was gen-
erated using a rotating brush aerosol generator followed 
by a  63Ni charge neutralizer to reduce the electrostatic 
charge on fibers to Boltzmann equilibrium. The aerosol 
was then delivered directly into the nose-only flow-past 
exposure chamber.
Control animals were exposed to filtered air passed 
through a separate brush-feed generator.
The  aerosol  mass  was  sampled  for  ~  5 h  during 
each exposure. Aerosol samples were collected on the 
appropriate filters in the vicinity of the animal’s snout. 
Likewise, the temperature, relative humidity, and oxy-
gen  concentration  were  measured  on  atmosphere/
aerosol  samples  collected  directly  from  the  delivery 
tube in the breathing zone of the animals. Also, in order 
to monitor and control the gravimetric concentration 
of the sanded powder aerosol alone, filter samples were 
also taken from a sampling outlet following the micron-
izing jet mill.
The  methods  for  the  gravimetric  determination  of 
aerosol concentrations; sampling of fiber number and 
size distribution of aerosol concentrations; particle size of 
dust aerosol; counting rules for the evaluation of aerosol 
and lung burden samples by TEM; and clinical examina-
tion and body weights have been presented in Bernstein 
et al. (2008 and 2010).
Methods for determination of postexposure endpoints
Fiber  lung  burden  and  histopathology  were  initially 
analyzed immediately following the end of the 5th day 
of exposure. This was termed day 0 of the nontreatment 
postexposure period.
Postexposure endpoints were developed in order to 
best answer the questions posed by this study. In the 
lung, these included:
determination of the size and number of fibers in the  •	
lung in order to determine the biopersistence of the 
fibers,
pathological response to the presence of fibers using  •	
histological examination, and
confocal microscopic examination in order to deter- •	
mine  the  lung  compartments  in  which  the  fibers 
are located and to visualize the juxtaposition of the 
fibers  within  the  lung  and  any  associated  cellular 
response.366  D.M. Bernstein et al.
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 In the pleura, endpoints included:
determination of the size and number of fibers on the  •	
diaphragm as a representative parietal pleural tissue, 
and any associated pathological response as a func-
tion of time postexposure, and
examination of the lung pleural/interface using fro- •	
zen chest sections in order to examine noninvasively 
the translocation of fibers to the pleural cavity and 
any pathological response.
 Table 1 summarizes the end points analyzed in subgroups 
of rats at each of the postexposure time points shown. 
The detailed specifications of these methods have been 
presented in Bernstein et al. (2010).
Two methods were used to perform this analysis.
Diaphragm
A biopsy punch (10 mm diameter) was used to collect tis-
sue discs of a uniform area of parietal pleural for micro-
scopic analysis. Fields of view were randomly selected 
and stacks of 25 serial sections each were recorded. Five 
fields of view were recorded from each parietal pleural tis-
sue specimen. The dimensions of voxels in the recorded 
volume were (x, y, and z dimensions, respectively) 0.17, 
0.17, and 0.39 μm.
SEM image collection and analysis
Parietal pleural tissue specimens prepared for SEM were 
brought  into  focus  at  1000×  magnification.  Random 
fields of view were recorded from each tissue piece and 
SEM image data were analyzed for inflammatory cells 
and fiber profiles.
Reported are all fiber profiles in length classes begin-
ning with ≥3 µm. The procedure was to locate parietal 
pleural areas observed on the diaphragm, collect a series 
of images, move at least two field widths, and repeat the 
process.
The number of fibers in each field of view was counted 
by a human operator who was looking for the character-
istic bright points or lines, which indicated a reflective or 
refractile fiber. In instances where free ends of the fiber 
were observed, fiber length was recorded using three-
dimensional  measurement  techniques.  Fibers  in  the 
parietal pleura were categorized as occurring:
in contact with the parietal surface of tissue, and •	
within the parietal tissue. •	
Inflammatory cells
Pleural  macrophages  are  a  normal  constituent  of  the 
pleural space. Numerous free cells localized in pleural 
spaces would represent inflammatory cells at these time 
Table 1.  Postexposure end points analyzed in subgroups of rats at each time points shown.
Days after cessation of the 
5-day exposure Air control CSP Amosite asbestos
0 Fiber lung burden Fiber lung burden Fiber lung burden
Lung histopathology Lung histopathology Lung histopathology
Lung confocal microscopy Lung confocal microscopy Lung confocal microscopy
Pleura—diaphragm Pleura—diaphragm Pleura—diaphragm
1 — Fiber lung burden Fiber lung burden
2 — Fiber lung burden Fiber lung burden
7 — Fiber lung burden Fiber lung burden
Lung histopathology Lung histopathology
Lung confocal microscopy Lung confocal microscopy
Pleura—diaphragm Pleura—diaphragm
14 Fiber lung burden Fiber lung burden Fiber lung burden
Lung histopathology Lung histopathology Lung histopathology
Lung confocal microscopy Lung confocal microscopy Lung confocal microscopy
Pleura—diaphragm Pleura—diaphragm Pleura—diaphragm
30 Fiber lung burden Fiber lung burden Fiber lung burden
Lung histopathology Lung histopathology Lung histopathology
Lung confocal microscopy Lung confocal microscopy Lung confocal microscopy
Pleura—diaphragm Pleura—diaphragm Pleura—diaphragm
90 Fiber lung burden Fiber lung burden Fiber lung burden
Lung histopathology Lung histopathology Lung histopathology
Lung confocal microscopy Lung confocal microscopy Lung confocal microscopy
Pleura—diaphragm Pleura—diaphragm Pleura—diaphragm
181 Fiber lung burden Fiber lung burden Fiber lung burden
Pleura—frozen chest sections Pleura—frozen chest sections Pleura—frozen chest sections
272 Fiber lung burden Fiber lung burden Fiber lung burden
Pleura—frozen chest sections Pleura—frozen chest sections Pleura—frozen chest sections
363 Fiber lung burden Fiber lung burden Fiber lung burden
Pleura—frozen chest sections Pleura—frozen chest sections Pleura—frozen chest sectionsCSP pleural transfer and pathological response  367
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points. However, we determined that counting the num-
ber of free cells adherent to the parietal pleural surface 
did not produce a measurable observation. Therefore, we 
report instances of presence or absence in areas in which 
adherent cells appear to be accumulated. Groupings of 
more than three cells were considered to represent an 
inflammatory response.
Results
Validation of aerosol generation procedure
In this study, as described in the methods section above, 
the Grade 7 chrysotile fiber was prepared by passing it 
through a small-scale, table-top, Cyclotec 1093 Sample 
Mill (FOSS Tecator, Sweden). This is a low volume device, 
which separates the fiber bundles obviating thermal deg-
radation or contamination. Brorby et al. (2008) reported 
on the TEM size distribution of the primary fibers and 
bundles of the Grade 7 chrysotile sample used in this 
study. Figure 1 compares the size distribution as deter-
mined by TEM of the original chrysotile sample (Brorby, 
personal  communication)  with  that  of  the  chrysotile 
aerosol to which the animals were exposed in this study. 
The methods used in this study successfully separated 
the  thicker  fiber  bundles,  removed  the  thicker  fibers 
that were not respirable by the rat, and resulted in an 
aerosol exposure that was representative of the original 
material.
Validation of lung digestion procedure
Comparative CM was used to assure that the lung diges-
tion and TEM procedures used in this study did not affect 
the fiber dimensions of the chrysotile present in the lung 
(Bernstein et al., 2004).
The results of this analysis confirmed that there is a 
very  good  correlation  between  the  length  distribution 
as measured by the lung digestion procedure/TEM and 
the confocal methodology with a correlation r2 = 0.9. In 
addition, the TEM procedure does not reduce the length 
distribution of the fibers seen in confocal analysis. The 
mean number of fibers remaining at each time point for 
the chrysotile group showed a good correlation (r2 = 0.9) 
Figure 1.  Comparison of the size distribution as determined by TEM of the original chrysotile sample (Brorby, personal communication) 
with that of the chrysotile aerosol to which the animals were exposed in this study. (See colour version of this figure online at www.
informahealthcare.com/iht)368  D.M. Bernstein et al.
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between the TEM measurements from the lung digestion 
procedure and the measurements obtained by CM.
The analytical examination of both the aerosol and 
the lung samples using TEM included routinely chemical 
identification of fiber type using energy dispersive x-ray 
analysis (EDS), which allowed also the detection of the 
crystalline structure of the fibers by selected area elec-
tron  diffraction.  No  amphibole  (tremolite)  fibers  were 
detected in the chrysotile samples in any of the TEM/
EDS examinations.
The aerosol concentration and size distribution of all 
groups are shown in Table 2. The fiber aerosol concen-
trations were chosen based upon the EC protocol, which 
specifies that the exposure atmospheres should have at 
least  100  fibers/cm3  >  20 µm.  In  this  study,  additional 
chrysotile was added to the sanded material in order to 
achieve  the  mean  number  of  fibers/cm3  >  20 µm.  The 
resulting mean number of fibers per cm3 > 20 µm was 
295 for chrysotile and 201 for amosite. Figure 2 shows the 
mean number of fibers in the exposure atmospheres in 
each of the three length categories < 5 µm, 5–20 µm, and 
> 20 µm for the chrysotile and amosite aerosols.
The mean number of WHO fibers (defined as fibers 
> 5 μm long, < 3 μm wide, and with length:width ratios 
>  3:1;  WHO,  1985)  in  the  CSP  atmosphere  was  1496 
fibers/cm3, which is > 10,000 times the OSHA occu-
pational exposure limit of 0.1 fibers/cm3. The amosite 
exposure atmosphere had fewer shorter fibers, result-
ing in a mean of 584 WHO fibers/cm3. The mean total 
number of fibers of all sizes in the exposure atmosphere 
was 6543 fibers/cm3 for chrysotile and 953 fibers/cm3 
for amosite.
The bivariate length and diameter size distributions of 
the CSP aerosol and the amosite asbestos aerosol have 
been presented in Bernstein et al. (2010).
Fiber lung burdens
The mean concentrations and dimensions of the fibers 
recovered from the lungs at each time point for CSP and 
for amosite, respectively, are presented in Tables 3 and 4.
For the CSP-exposed rats (Table 3), the mean num-
ber  of  fibers  longer  than  20 µm  decreased  from  0.31 
million fibers L > 20 µm per lung immediately following 
exposure (day 0) to 0 fibers at 90 days. At day 0, fibers 
up to 90 µm in length were observed. The maximum 
fiber  length  steadily  decreased  from  7  days  onward 
and from 90 days through 365 days, with the maximum 
length in the range of 20–25 µm. (At 181 days, one fiber 
of 21 µm in length was observed on the filter aliquot 
analyzed  from  one  animal  and  at  275  and  365  days 
one fiber of 25 µm in length was observed on the filter 
aliquot  analyzed  from  one  animal.)  As  these  results 
were obtained through the lung digestion procedure, it 
was not possible to determine the association of these 
fibers with cells in particular macrophages. While in 
general the rat alveolar macrophage has been shown in 
vitro (Morimoto et al., 1994; Luoto et al., 1995; Zeidler-
Erdely et al., 2006) to engulf fibers up to 20 µm in length, 
the results suggest that an occasional macrophage can 
engulf a slightly longer fiber.
For the amosite-exposed rats (Table 4), the number 
of fibers longer than 20 µm decreased slightly from 2.74 
million fibers per lung immediately after exposure to 1.98 
million fibers per lung at 7 days postexposure and 1.4 
million fibers longer than 20 µm per lung observed at 365 
days. The maximum fiber length observed 0 days postex-
posure was 110 µm and remained very similar through-
out the 365 days postexposure period with a maximum 
length of 105 µm observed at 365 days.
Figures 3 and 4 show the bivariate length and diam-
eter distribution of fibers in the CSP and the amosite-
exposed lungs, respectively, immediately after cessation 
of exposure (day 0) and at 365 days after cessation of 
exposure. Only relatively short and thin fibers remain in 
the CSP-exposed lungs. For the amosite-exposed lungs, 
the thicker fibers, which likely deposited in the tracheo-
bronchial tree, have been cleared by 365 days. The distri-
bution of the thinner fibers remained remarkably similar 
to what was observed at 0 days postexposure.
The  clearance  of  fibers  from  the  lung  through  365 
days postexposure is shown in Figures 5 and 6 for the 
CSP-exposed animals and the amosite-exposed animals, 
respectively. Each figure shows the data and clearance 
curves  for  fibers  <  5 µm  in  length,  fibers  5–20 µm  in 
length, and fibers > 20 µm in length. Individual values for 
each animal and each size fraction are shown as are the 
clearance curves and the clearance half-times. For the 
CSP-exposed animals, the clearance curves were best fit 
using nonlinear estimation to a single exponential. For 
the amosite-exposed animals, the clearance curves were 
best  fit  using  nonlinear  estimation  to  a  double  expo-
nential; with the clearance half-times expressed as the 
weighted T1/2 (EUR 18748 EN., 1999).
In the CSP-exposed animals (Figure 5), the fibers lon-
ger than 20 µm were rapidly cleared from the lung with 
a clearance half-time of 4.5 days. The fibers 5–20 µm in 
length were cleared with a half-time of 12.8 days, while 
the fibers < 5 µm in length cleared with a half-time of 27.8 
days.
In the amosite-exposed animals (Figure 6), the num-
ber of fibers longer than 20 µm remaining in the lung 
showed a small reduction immediately following expo-
sure with little subsequent clearance from the lung, with 
a weighted clearance half-time of > 1000 days. This initial 
reduction is likely due to fibers that deposited in the tra-
chea-bronchial tree. The fibers 5–20 µm in length and the 
fibers < 5 µm in length also showed an initial reduction 
immediately following cessation of exposure. However, 
the strong inflammatory response created by the longer 
fibers appears to have locked-up the shorter fibers as 
well, with a weighted clearance half-time > 1000 days for 
these smaller length fractions.
Histopathological results
The results from the histopathological examination of 
the lungs have been presented in detail in Bernstein CSP pleural transfer and pathological response  369
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et  al.  (2010).  These  findings  confirmed  that  animals 
exposed to CPP produced no sign of pulmonary inflam-
mation,  aside  from  a  macrophage  response,  at  any 
time point. In contrast, the animals exposed to amosite 
asbestos  showed  a  marked  inflammatory  response 
starting immediately after cessation of exposure (day 
0). By 28 days postexposure, the lungs exhibited inter-
stitial  fibrosis  with  a  Wagner  Grade  4.  These  lesions 
were observed both in the conventional histopathologi-
cal micrographs and in the 3D confocal micrographs. 
Because CM permits noninvasive imaging of a cube of 
tissue,  micrographs  using  this  technique  were  espe-
cially useful in showing the juxtaposition of especially 
the long amosite fibers in the tissue and their relation-
ship to the observed lesions.
Translocation of fibers to the pleural cavity and 
subsequent response
One important objective of this study was to examine the 
translocation of fibers to the pleural cavity using noneva-
sive techniques and to evaluate the possible response to 
the fibers.
Two methods were used to perform this analysis. The 
examination of the diaphragm as a representative pari-
etal pleural tissue was performed on the same animals 
that  were  examined  for  lung  histopathology  and  CM. 
These  animals  were  examined  at  time  points  starting 
at 0 days, immediately following cessation of exposure, 
through 90 days postexposure. The examination of the 
visceral pleural and the subvisceral pleural regions of the 
lung was performed on subgroups of animals starting 
at 181 days through 365 days postexposure. The visceral 
pleural examination method required immediate deep 
freezing  of  the  rats  following  killing,  which  precluded 
other analyses and thereby accounted for the differential 
timing between the two methods.
Diaphragm
The number of fibers in each field of view (average field 
of view was 0.03 mm2) was counted by a human opera-
tor, who was looking for the characteristic bright points 
or lines, which indicate a reflective or refractile fiber. In 
instances where free ends of the fiber were observed, 
fiber length was recorded using three-dimensional mea-
surement techniques. Fibers in the parietal pleura were 
categorized as occurring:
in contact with parietal surface of tissue, or •	
within the parietal tissue. •	
Inflammatory response to fibers
While pleural macrophages are a normal constituent of 
the pleural fluid (Noppen et al., 2000), the likelihood of 
finding  individual  macrophages  adherent  to  the  pari-
etal pleural surface is small. Instead, examination was 
directed in areas in which adherent cells appear to be 
accumulated. Groupings of more than three cells (mac-
rophages,  neutrophils,  etc.)  were  considered  as  repre-
senting an inflammatory response.
In animals exposed to CSP, no parietal pleura lesions 
were observed at any time points studied. The parietal 
pleura  surface  from  an  animal  exposed  to  CSP  at  90 
days postexposure is shown in Figure 7. An occasional 
macrophage is observed, however, there is no associated 
inflammatory response or lesions.
In  animals  exposed  to  amosite  asbestos,  when 
amosite fibers were observed on the parietal pleural 
surface, enlarged macrophages adherent to the pari-
etal surface were also observed. Macrophages exhib-
ited  extended  pseudopodia  with  Lamella  project  a, 
which is indicative of activated macrophages. Fibrotic 
lesions were also occasionally observed. As shown in 
Figure  8,  a  network  of  large  activated  macrophages 
and an associated fibrin matrix network was observed 
on the parietal pleural surface at 14 days postexposure. 
At 90 days postexposure, numerous macrophages were 
observed on the parietal pleural as shown in Figure 9 
(The  triangular  indentation  seen  in  the  micrograph 
was likely due to the back of a forceps, which was used 
for  straightening  the  diaphragm  after  removal  from 
the animal). Confocal imaging of the diaphragm has 
indicated the presence of a number of amosite fibers 
in this region.
Visceral pleural examination
While examination of the diagram provided a unique 
opportunity to examine the differential response on the 
parietal pleural surface, how fibers are transported to 
the pleural cavity and what impact they may have on 
the  visceral  pleural  barrier  have  long  been  an  open 
question.
To address this issue, the visceral pleural was sys-
tematically examined from cross-sections of rats that 
were frozen in liquid nitrogen immediately following 
sacrifice.  This  procedure  was  used  in  order  to  avoid 
possible artifacts that could stem from cross-contami-
nation of fibers from the lung to the pleural cavity when 
tissues are manipulated at necropsy. The examination 
included a systematic survey using CM of the visceral 
pleural  wall,  the  adjacent  subpleural  alveoli  and  the 
pleural space. The features of the tissues were evaluated 
Figure 2.  The mean number of fibers in the exposure atmospheres 
in  each  of  the  three  length  categories  <  5 µm,  5–20 µm,  and  > 
20 µm are illustrated for the CSP and amosite aerosols. (See colour 
version of this figure online at www.informahealthcare.com/iht)CSP pleural transfer and pathological response  371
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and the location and length of any fibers present were 
determined.
In  addition,  the  thickness  of  the  pleural  wall  was 
measured at between 5 and 10 points in each section 
examined.  The  results  of  this  analysis  are  shown  in 
Figure 10. The visceral pleural wall averaged ~ 2 µm in 
thickness in the air control group. The width ranged 
from < 1 µm to ~ 7 µm and remained relatively constant 
from  181  days  through  365  days  postexposure.  The 
visceral pleural thickness in the CSP-exposed rats was 
nearly identical to that of the air control animals with 
no statistical difference at any time point.
In the amosite-exposed rats, the mean visceral pleu-
ral thickness was ~ 5 µm, more than double that of the 
air control and CPS exposure groups. This difference 
was statistically significant at all-time points from 181 
to 365 days (Dunnett’s t-test, p < 0.01). The thickness 
of the visceral pleural in the amosite-exposed animals 
ranged from ~ 1 µm to > 20 µm.
Another measure of effect was the determination 
of  pleural  defects.  Pleural  defects  were  defined  as 
a change in the pleural surface (visceral or parietal) 
thickness  or  surface  interface  appearance  as  indi-
cated by connective tissue increase, accumulation of 
cells, or, in the case of visceral pleural side, appear-
ance of subpleural alveolar involvement by inflamma-
tory cells or connective tissue. The average number 
of pleural defects per field of view (average field of 
view was 0.0075 mm2) is shown in Figure 11. No pleu-
ral defects were observed in either the air control or 
the  CSP-exposed  animals  at  any  time  point.  In  the 
amosite-exposed rats, the number of pleural defects 
per field of view ranged from 40 at 181 days to > 15 at 
365 days.
The number and length of fibers present at the vis-
ceral surface were also quantified as shown in Figure 12. 
No fibers were observed at the visceral pleural surface 
in the air control or the CSP-exposed animals at 181, 
Figure 3.  Bivariate length and diameter distribution of fibers in the CSP-exposed lungs, respectively, immediately after cessation of 
exposure (day 0) and at 365 days after cessation of exposure. (See colour version of this figure online at www.informahealthcare.com/iht)
Figure 4.  Bivariate length and diameter distribution of fibers in the amosite-exposed lungs, respectively, immediately after cessation of 
exposure (day 0) and at 365 days after cessation of exposure. (See colour version of this figure online at www.informahealthcare.com/iht)374  D.M. Bernstein et al.
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275, or 365 days postexposure. In the amosite-exposed 
animals, an average of 16 fibers were observed at 181 
days,  10  fibers  at  272  days,  and  4  fibers  at  365  days 
normalized to a mean observed parietal pleural area of 
0.01 mm2. The fiber length observed ranged from ~ 1 µm 
to > 12.5 µm.
Figure 6.  The clearance of fibers from the lung through 365 days postexposure is shown for amosite-exposed animals. The data and 
clearance curves for fibers < 5 µm in length, fibers 5–20 µm in length, and fibers > 20 µm in length are presented. (See colour version of this 
figure online at www.informahealthcare.com/iht)
Figure 5.  The clearance of fibers from the lung through 365 days postexposure is shown for CSP-exposed animals. The data and clearance 
curves for fibers < 5 µm in length, fibers 5–20 µm in length, and fibers > 20 µm in length are presented. (Note that the axis for the number of 
fibers remaining in the lung > 20 µm is on the right side of the graph.) (See colour version of this figure online at www.informahealthcare.
com/iht)CSP pleural transfer and pathological response  375
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Examination of the visceral pleura interface
Air control
A typical view of the pleural space at 181 days postex-
posure from a control animal is shown in Figure 13. The 
subpleural  alveolar  septa  is  seen  on  the  left  with  the 
parietal pleura shown on the right. The brighter white is 
indicative of collagen in the visceral and parietal pleural 
walls. Free macrophages are present within the pleural 
space (bottom middle).
The  pleural  space  at  272  days  postexposure  from  a 
control animal is very similar as shown in the confocal 
micrograph in Figure 14. The subpleural alveolar septa 
adjacent to visceral pleura are seen on the left, pleural 
space in the middle, and parietal pleura with the chest 
on the right.
CSP
A typical field of view from an animal exposed to CSP 
mixture at 272 days postexposure is shown in Figure 15. 
This confocal micrograph is very similar to that seen for 
the air control (Figure 14).
Amosite asbestos
A confocal 3D micrograph of the visceral pleura and the 
adjacent subpleural alveoli from an animal exposed to 
amosite asbestos at 181 days postexposure is shown in 
Figure 16. Amosite fibers are seen in a subpleural granu-
loma with numerous alveolar macrophages in the sub-
pleural alveoli.
Figure 17 shows an amosite fiber ~ 39 µm in length 
within a subpleural granuloma at 272 days postexposure. 
The right edge of this long fiber pierces the subpleural 
capsule. The thicker bright white matrix is indicative of a 
fibrotic thickening of the visceral pleura.
A  typical  field  of  view  from  an  animal  exposed  to 
amosite asbestos at 272 days postexposure is shown in 
Figure 18. The subpleural alveolar septa seen in the left 
center  of  the  image  contains  fibrotic  lesions  (thicker 
bright  white  matrix,  which  is  indicative  of  enhanced 
collagen deposition). The parietal pleura and chest wall 
is shown on the right. Within the alveolus on the left, a 
number of subpleural macrophages can be seen.
Figure  19  shows  an  amosite  fiber  penetrating  the 
visceral pleural wall into the pleural space at 365 days 
following cessation of exposure. On the lung side, a well-
developed subpleural granuloma is seen with alveolar 
macrophages on the surface.
Discussion
Within the lung
As presented above, the exposure concentration of fibers 
longer  than  20 µm/cm3  was  more  than  double  in  the 
Figure 9.  The parietal pleural surface from an animal exposed to 
amosite asbestos at 90 days postexposure. Numerous macrophages 
are observed on the parietal pleural (the triangular indentation 
seen in the micrograph was likely due to the back of a forceps, 
which was used for straightening the diaphragm after removal 
from the animal). Confocal imaging of the diaphragm indicated 
the presence of a number of amosite fibers in this region.
Figure 8.  The parietal pleural surface from an animal exposed 
to amosite asbestos at 14 days postexposure. A network of large 
activated macrophages, which have laid down a fibrin matrix, is 
observed.
Figure 7.  The parietal pleural surface from an animal exposed 
to  CSP  at  90  days  postexposure.  An  occasional  macrophage  is 
observed; however, there is no associated inflammatory response 
or lesions.376  D.M. Bernstein et al.
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CSP-exposed rats as compared to the amosite-exposed 
rats and in both cases exceeded the number of fibers 
recommended in the protocol (ECB/TM/26 rev.7, 1999). 
Immediately following cessation of the 5-day exposure, 
the number of fibers > 20 µm in length remaining in the 
lung was 0.31 million for the CSP-exposed rats as com-
pared to 2.74 million for the amosite-exposed rats. This 
is a result of the longer amosite fibers not dissolving or 
breaking apart in the lung in contrast to the chrysotile 
fibers, which rapidly break apart and are cleared.
Figure 10.  The thickness of the pleural wall measured at between 5 and 10 points in each section examined is shown for the air control, 
CSP, and amosite asbestos-exposed groups. The mean visceral wall thickness of the amosite-exposed group was statistically larger 
than the mean visceral wall thickness of the chrysotile or air-control groups (Dunnett’s T-test, P < 0.01).
Figure 11.  The average number of pleural defects per field of view (average field of view was 0.0075 mm2) is shown for the air control, CSP, 
and amosite asbestos-exposed groups.CSP pleural transfer and pathological response  377
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CSP
Chrysotile fibers are thin (0.8 angstroms) rolled sheets 
composed of magnesium silicate. The magnesium is on 
the outside of the sheet and can be solubilized in the 
alveolar surfactant. The crystalline structure of the silica 
matrix is attacked and broken apart by the acid envi-
ronment of macrophages recruited in response to any 
inhaled particle (Pundsack, 1955; Wypych et al., 2005).
In this study, the CSP began clearing from the lung 
immediately following deposition, with a clearance half-
time for fibers longer than 20 µm of 4.5 days. By the end of 
Figure 12.  The number and length of fibers present at the visceral surface are shown.
Figure 13.  View of the pleural space at 181 days postexposure from 
a control animal is shown in the confocal image. The subpleural 
alveolar septa is seen on the left with the parietal pleura shown 
on the right. The brighter white is indicative of collagen in the 
visceral and parietal pleural walls. Free macrophages are present 
within the pleural space (bottom middle).
Figure 14.  View of the pleural space at 272 days postexposure from 
a control animal is shown in the confocal image. The subpleural 
alveolar septa is seen on the left with the parietal pleura shown on 
the right. The brighter white is indicative of collagen in the visceral 
and parietal pleural walls.378  D.M. Bernstein et al.
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the 5-day exposure, more than 90% of the inhaled fibers 
longer  than  20 µm  had  already  been  cleared  from  the 
lung (as compared to the amosite exposure in which the 
longer fibers were not cleared).
Once deposited in the lung, the longer chrysotile fibers 
quickly broke apart into shorter pieces. As reported earlier 
(Bernstein et al., 2010), fibers were initially deposited on 
the bronchial and alveolar surfaces with very few fibers 
found in the interstitial space. Those that were observed 
in the interstitial space were quickly removed and by 90 
days postexposure, the remaining fibers were found only 
in  the  macrophages.  No  inflammatory  or  pathological 
response was associated at any time point with exposure 
to CSP.
The fibers between 5 and 20 µm in length had a clear-
ance half-time of 12.8 days, and those fibers < 5 µm in 
length  had  a  clearance  half-time  of  27.8  days.  These 
slightly  longer  clearance  half-times  for  the  shorter 
fibers are probably due to the large number of fibers 
being created as the longer fibers break apart. These 
clearance  half-times  are  still  considerably  less  than 
those found for insoluble particles (Stoeber et al., 1970; 
Muhle et al., 1987). These values are similar to those 
presented in the interim result publication based upon 
the data through 90 days postexposure (Bernstein et al., 
2010).
These results are comparable to those reported pre-
viously for pure chrysotile exposures (Bernstein et al., 
2004, 2005a,b) and are consistent with the pilot study on 
CSP (Bernstein et al., 2008).
Amosite asbestos
While CSP in the lung clears rapidly and produces no 
pathology, the amosite asbestos exposure group showed 
a markedly different response. Amosite has a notably dif-
ferent physical form than chrysotile. While chrysotile is 
a rolled thin sheet, amosite asbestos is a double-chain 
silicate formed as a solid cylinder of silica. Amosite has 
a very low dissolution coefficient even in an acid envi-
ronment at environmental or human body temperatures. 
Amosite asbestos is biopersistent in both the lung and 
in the macrophage environments (Speil & Leineweber, 
1969).
Following deposition in the lung, all fiber lengths of 
amosite persist with clearance half-times of > 1000 days, 
which  is  greater  than  the  lifetime  of  the  rat.  For  fiber 
lengths 5–20 µm and longer than 20 µm, these results are 
similar to the interim results presented in Bernstein et al. 
(2010) through 90 days postexposure. For the fibers < 5 µm 
in length, in the earlier publication, a clearance half-time 
of  90  days  was  estimated.  However,  incorporating  the 
full set of data through 365 days, even the short fibers no 
longer clear after 90 days postexposure, most likely being 
locked up in the intense inflammatory response caused 
by the longer fibers.
Already by the end of the 5-day exposure, an intense 
inflammatory  response  to  amosite  was  observed 
Figure 16.  View of the pleural space from an animal exposed to amosite asbestos at 181 days postexposure. Amosite fibers are seen in a 
subpleural granuloma with numerous alveolar macrophages in the subpleural alveoli.
Figure 15.  View of the pleural space from an animal exposed to 
CSP mixture at 272 days postexposure is shown in the confocal 
image. This confocal micrograph is very similar to that seen for 
the air control (Figure 14).CSP pleural transfer and pathological response  379
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including  granuloma  formation  around  the  longer 
fibers, which the macrophages could not clear. By 28 
days postexposure, the continued inflammation resulted 
in the formation of interstitial fibrosis. The response to 
amosite is similar to that of another amphibole asbestos, 
tremolite, that has been studied previously (Bernstein 
et al., 2005b).
Immediately after the end of exposure, amosite fibers 
were  observed  penetrating  the  airway  wall,  located 
completely under the airway wall, as well as within mac-
rophages on the surface of the ciliated epithelium. In the 
lung parenchyma, a small number of fibers were observed 
partly or fully embedded into the interstitial space with 
fibers wholly or partly inside alveolar macrophages and 
touching alveoli, alveolar ducts, or respiratory bronchi-
oles (Bernstein et al., 2010).
In contrast to the chrysotile fibers, at 90 days postex-
posure the amosite fibers were still observed penetrating 
the airway wall or located completely underneath the 
airway wall and on the surface of the ciliated epithelium. 
Even  more  important  in  terms  of  disease  formation, 
substantial number of amosite fibers were found partly 
or fully embedded into the interstitial space with fibers 
observed wholly or partly inside alveolar macrophages 
and touching alveoli, alveolar ducts, or respiratory bron-
chioles (Bernstein et al., 2010).
The  fibrotic  response  seen  in  this  study  following 
exposure to the amphibole amosite asbestos is similar 
to that reported in humans by Schneider et al. (2010). 
Schneider et al. (2010) reported that the fibrosis scores 
of the asbestosis cases correlated best with the number 
of uncoated commercial amphibole fibers.
Translocation to the visceral pleura and then to the 
parietal pleura
CSP
Systematic examination of the region of the lung imme-
diately adjacent to the visceral pleural and the visceral 
pleural itself using samples taken from frozen rats demon-
strates no chrysotile fibers at any time point. In addition, 
no inflammatory cells or increase in collagen formation 
are observed at any time point, that is the tissue appears 
normal as it does in the negative control group. The thick-
ness of the visceral pleural wall in the CSP-exposed ani-
mals was the same as that in the air control group.
Similarly, examination of the diaphragm as a repre-
sentative parietal pleural tissue shows no indication of 
Figure 18.  View of the pleural space from an animal exposed to 
amosite asbestos at 272 days postexposure. The subpleural alveolar 
septa seen in the left center of the image contains fibrotic lesions 
(thicker bright white matrix is indicative of enhanced collagen 
deposition). The parietal pleura and chest wall is shown on the 
right.  Within  the  alveolus  on  the  left,  a  number  of  subpleural 
macrophages can be seen.
Figure 17.  View of the pleural space from an animal exposed to 
amosite asbestos at 272 days postexposure. An amosite fiber ~ 
39 µm in length is observed within a subpleural granuloma. The 
right edge of this long fiber pierces the subpleural capsule. The 
thicker bright white matrix is indicative of a fibrotic thickening of 
the visceral pleura.
Figure  19.  View  of  the  pleural  space  from  an  animal  exposed 
to amosite asbestos at 365 days postexposure. An amosite fiber 
penetrating the visceral pleural wall into the pleural space is seen. 
On the lung side, a well-developed subpleural granuloma is seen 
with alveolar macrophages on the surface.380  D.M. Bernstein et al.
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any inflammation at any time point in the CSP-exposed 
group. Unexpected interference was found in the signal 
from the confocal examination most likely due to protein 
coatings on the parietal pleural surface. As a result, the 
fiber  examination  can  only  be  considered  qualitative, 
not quantitative. In the CSP-exposed group, there was an 
indication of two possible shorter fibers present in one 
animal  at  30  days  postexposure.  No  other  fibers  were 
identified,  and  there  was  no  cellular  or  inflammatory 
response associated with the two possible fibers.
Amosite asbestos
The  range  of  pathological  response  observed  in  the 
amosite-exposed animals appears to mirror quite closely 
that which is observed in humans exposed to amphibole 
asbestos.  Systematic  examination  of  the  region  of  the 
lung immediately adjacent to the visceral pleural and of 
the visceral pleural itself using samples taken in the fro-
zen rat procedure has shown the presence of numerous 
amosite fibers as shown in Figures 16, 17, and 19. Figure 
17 shows an amosite fiber ~ 40 µm in length in the lung 
directly adjacent to the visceral pleural surface with one 
end piercing the visceral pleural capsule. Figure 19 shows 
an amosite fiber penetrating the visceral wall from the 
lung into the pleural space. An important inflammatory 
response with numerous macrophages and possibly other 
cells present is associated with these amosite fibers.
The confocal methodology used in this study is quantita-
tive in the assessment of excess collagen in the lung assayed 
by hydroxyproline (Antonini et al., 1999). The collagen is 
seen in the confocal micrographs as the bright white areas 
with  the  intensity  of  the  brightness  proportional  to  the 
amount of collagen. The normal lung as seen in the air con-
trols in Figures 13 and 14 shows the normal collagen struc-
ture of the visceral and parietal walls as thin white lines on 
each side of the pleura. A nearly identical image seen in the 
CSP-exposed group is shown in Figure 15.
In the amosite-exposed group, as shown in Figure 17, 
both the visceral and the parietal pleural walls show a 
fibrotic response as indicated by the much brighter and 
thicker visceral and parietal surfaces on each side of the 
pleural space.
Adjacent to the end of the fiber (Figure 17), which is 
piercing the visceral pleural capsule, is a bridge to the pari-
etal pleural surface, which is most likely an adhesion. In 
Figure 18, another example of adhesions between the vis-
ceral and parietal walls of the pleural cavity is seen in more 
detail with the folds of the adhesion appearing to extend 
out from the visceral surface to the parietal pleural surface.
The mean thickness of the visceral pleural wall in the 
amosite-exposed animals was more than twice that in 
the air control and the CSP. While the thickness of the air 
control and the CSP-exposed animals ranged up to 7 µm, 
that of the amosite-exposed animals ranged up to 21 µm. 
The greater thickness of the visceral wall in the amosite-
exposed  animals  was  associated  with  the  presence  of 
amosite fibers in these regions.
Amosite diaphragm
While the examination of the visceral pleural surface 
was performed in the frozen rat sections at intervals 
from 181 to 365 days postexposure, the examination 
of  the  parietal  pleural  surface  (diaphragm)  was  per-
formed  at  earlier  intervals  (between  0  and  90  days 
postexposure).
One  of  the  most  interesting  results  of  this  study 
is  how  quickly  the  amosite  fibers  reach  the  parietal 
pleural surface and initiate an inflammatory response. 
Within 7 days after the cessation of exposure, amosite 
fibers can be seen by CM on the diaphragm. By 14 days, 
an inflammatory response to these fibers was seen as 
shown in Figure 8. In addition, a fibrin matrix formed 
on the parietal pleural surface. Pleural injury and repair 
is characterized by disordered fibrin turnover, which 
contributes to the pathogenesis of pleural fibrosis. This 
is an early marker of pleural injury, and it has been pro-
posed that disordered fibrin turnover plays a central 
role in the pathogenesis of pleural fibrosis. Fibrinogen 
is  converted  to  fibrin  forming  the  transitional  intra-
pleural  neomatrix  when  intrapleural  coagulation  is 
activated by chemical or inflammatory stimuli (Jantz & 
Antony 2008; Shetty et al., 2008).
The formation of fibrin has also been associated with 
the development of adhesions between the visceral and 
parietal pleural walls (Idell et al., 2001) as shown in Figure 
18. Intrapleural coagulation is initiated by increased local 
expression of tissue factors in response to the local injury 
and  fibrinolysis  is  concurrently  downregulated,  due  to 
primarily increased expression of PAI-1 and downstream 
antiplasmins. Formation of adhesions between the visceral 
and parietal pleural surfaces occurs in association with 
intrapleural coagulation and downregulation of fibrinoly-
sis (Shetty et al., 2008). Pleural adhesions and fusion of the 
visceral and parietal pleura commonly occur with the dif-
fuse pleural thickening (Huggins & Sahn, 2004), which was 
observed for amosite asbestos in this study (Figure 10).
In the quantification of the number of fibers in the CM 
examination of the visceral pleura, the area of the visceral 
pleural surface examined was recorded for each animal 
individually  and  ranged  from  a  mean  per  time  point 
examined of 0.0038–0.0076 mm2. The total pleural surface 
area of the rat has been reported as 2450 mm2 (Bermudez 
et al., 2003), and approximately one-half of this would 
represent the visceral pleural surface. Based upon this 
and the number of fibers observed in these areas, and 
assuming that the distribution is uniform throughout the 
visceral pleura, the total fiber burden of the visceral pleura 
would be in the range of a few million fibers (all lengths).
conclusions
This study is unique in that it has examined a commercial 
joint compound product that historically used chrysotile 
and it quantified not only the pathological response and 
fiber distribution by compartment in the lung, but also CSP pleural transfer and pathological response  381
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the translocation of fibers to and pathological response 
in the pleural cavity.
The translocation to and pathological response in the 
pleura was examined by SEM and CM using noninvasive 
methods. The number and size of fibers was quantified 
using TEM and CM. This is the first study to use such 
techniques to characterize fiber translocation to and the 
response of the pleural cavity.
Amosite fibers were found to remain partly or fully 
imbedded in the interstitial space through 1 year postex-
posure  and  quickly  produced  granulomas  (0  days) 
and  interstitial  fibrosis  (28  days).  Amosite  fibers  were 
observed penetrating the visceral pleural wall and were 
found on the parietal pleural within 7 days postexposure 
with a concomitant inflammatory response seen by 14 
days postexposure. Pleural fibrin deposition, fibrosis, and 
adhesions were also observed in response to the amosite 
and were similar to that observed in humans in response 
to amphibole asbestos.
No cellular or inflammatory response was observed 
in the lung or the pleural cavity in response to the CSP 
exposure.
These results provide confirmation of the important 
differences  between  CSP  compound  and  amphibole 
asbestos.
Declaration of interest
This work was supported by a grant from Georgia-Pacific, 
LLC.
References
Agostoni  E,  Zocchi  L.  1998.  Mechanical  coupling  and  liquid 
exchanges in the pleural space. Clin Chest Med 19:241–260.
Antonini JM, Charron TG, Roberts JR, Lai J, Blake TL, Rogers RA. 
1999. Application of laser scanning confocal microscopy in the 
analysis  of  particle-induced  pulmonary  fibrosis.  Toxicol  Sci 
51:126–134.
Bermudez E, Mangum JB, Moss OR, Wong BA, Everitt JI. 2003. Pleural 
dosimetry  and  pathobiological  responses  in  rats  and  hamsters 
exposed  subchronically  to  MMVF  10a  fiberglass.  Toxicol  Sci 
74:165–173.
Bernstein  DM,  Hoskins  JA.  2006.  The  health  effects  of  chrysotile: 
current  perspective  based  upon  recent  data.  Regul  Toxicol 
Pharmacol 45:252–264.
Bernstein  DM,  Rogers  R,  Smith  P.  2004.  The  biopersistence  of 
brazilian chrysotile asbestos following inhalation. Inhal Toxicol 
16:745–761.
Bernstein  DM,  Chevalier  J,  Smith  P.  2005.  Comparison  of  Calidria 
chrysotile asbestos to pure tremolite: final results of the inhalation 
biopersistence and histopathology examination following short-
term exposure. Inhal Toxicol 17:427–449.
Bernstein  DM,  Donaldson  K,  Decker  U,  Gaering  S,  Kunzendorf  P, 
Chevalier  J,  Holm  SE.  2008.  A  biopersistence  study  following 
exposure to chrysotile asbestos alone or in combination with fine 
particles. Inhal Toxicol 20:1009–1028.
Bernstein D, Rogers R, Smith P. 2005. The biopersistence of Canadian 
chrysotile  asbestos  following  inhalation:  final  results  through  1 
year after cessation of exposure. Inhal Toxicol 17:1–14.
Bernstein  DM,  Rogers  RA,  Sepulveda  R,  Donaldson  K,  Schuler 
D,  Gaering  S,  Kunzendorf  P,  Chevalier  J,  Holm  SE.  2010.  The 
pathological response and fate in the lung and pleura of chrysotile 
in combination with fine particles compared to amosite asbestos 
following short-term inhalation exposure: interim results. Inhal 
Toxicol 22:937–962.
Brorby  GP,  Sheehan  PJ,  Berman  DW,  Greene  JF,  Holm  SE.  2008. 
Re-creation of historical chrysotile-containing joint compounds. 
Inhal Toxicol 20:1043–1053.
Cannon WC, Blanton EF, McDonald KE. 1983. The flow-past chamber: 
an improved nose-only exposure system for rodents. Am Ind Hyg 
Assoc J 44:923–928.
European  Commission.  1999.  ECB/TM/26  rev.7.  Methods  for  the 
determination  of  the  hazardous  properties  for  human  health 
of  man  made  mineral  fibers  (MMMF).  European  Commission. 
Joint Research search Centre, Institute for Health and Consumer 
Protection, Unit: Toxicology and Chemical Substances, European 
Chemicals Bureau.
Fentie  IH,  Allen  DJ,  Schenck  MH,  Didio  LJ.  1986.  Comparative 
electron microscopic study of bovine, porcine and human parietal 
pericardium,  as  materials  for  cardiac  valve  bioprostheses.  J 
Submicrosc Cytol 18:53–65.
Hesterberg  TW,  Chase  G,  Axten  C,  Miller  WC,  Musselman  RP, 
Kamstrup  O,  Hadley  J,  Morscheidt  C,  Bernstein  DM,  Thevenaz 
P. 1998. Biopersistence of synthetic vitreous fibers and amosite 
asbestos  in  the  rat  lung  following  inhalation.  Toxicol  Appl 
Pharmacol 151:262–275.
Hesterberg  TW,  Axten  C,  McConnell  EE,  Hart  GA,  Miiller  W, 
Chevalier J, Everitt J, Thevenaz P, Oberdörster G. 1999. Studies 
on  the  inhalation  toxicology  of  two  fiberglasses  and  amosite 
asbestos  in  the  syrian  golden  hamster.  Part  I.  Results  of  a 
subchronic study and dose selection for a chronic study. Inhal 
Toxicol 11:747–784.
Hesterberg  TW,  Axten  C,  McConnell  EE,  Oberdörster  G,  Everitt  J, 
Miiller  WC,  Chevalier  J,  Chase  GR,  Thevenaz  P.  1997.  Chronic 
inhalation study of fiber glass and amosite asbestos in hamsters: 
twelve-month  preliminary  results.  Environ  Health  Perspect  105 
Suppl 5:1223–1229.
Huggins JT, Sahn SA. 2004. Causes and management of pleural fibrosis. 
Respirology 9:441–447.
Idell S, Mazar AP, Bitterman P, Mohla S, Harabin AL. 2001. Fibrin 
turnover in lung inflammation and neoplasia. Am J Respir Crit 
Care Med 163:578–584.
Jantz MA, Antony VB. 2008. Pathophysiology of the pleura. Respiration 
75:121–133.
Luoto K, Holopainen M, Kangas J, Kalliokoski P, Savolainen K. 1995. 
The effect of fiber length on the dissolution by macrophages of 
rockwool and glasswool fibers. Environ Res 70:51–61.
McConnell EE, Axten C, Hesterberg TW, Chevalier J, Miiller WC, Everitt 
J, Oberdörster G, Chase GR, Thevenaz P, Kotin P. 1999. Studies on 
the inhalation toxicology of two fiberglasses and amosite asbestos 
in the Syrian golden hamster. Part II. Results of chronic exposure. 
Inhal Toxicol 11:785–835.
Morimoto Y, Yamato H, Kido M, Tanaka I, Higashi T, Fujino A, Yokosaki 
Y. 1994. Effects of inhaled ceramic fibres on macrophage function 
of rat lungs. Occup Environ Med 51:62–67.
Muhle H, Pott F, Bellmann B, Takenaka S, Ziem U. 1987. Inhalation 
and  injection  experiments  in  rats  to  test  the  carcinogenicity  of 
MMMF. Ann Occup Hyg 31:755–764.
Noppen M, De Waele M, Li R, Gucht KV, D’Haese J, Gerlo E, Vincken 
W. 2000. Volume and cellular content of normal pleural fluid in 
humans examined by pleural lavage. Am J Respir Crit Care Med 
162:1023–1026.
Peng MJ, Wang NS, Vargas FS, Light RW. 1994. Subclinical surface 
alterations  of  human  pleura.  A  scanning  electron  microscopic 
study. Chest 106:351–353.
Pundsack FL. 1955. The properties of asbestos. I. The colloidal and 
surface chemistry of chrysotile. J Phys Chem 59:892–895.
Rogers  RA,  Antonini  JM,  Brismar  H,  Lai  J,  Hesterberg  TW, 
Oldmixon EH, Thevenaz P, Brain JD. 1999. In situ microscopic 
analysis of asbestos and synthetic vitreous fibers retained in 
hamster lungs following inhalation. Environ Health Perspect 
107:367–375.382  D.M. Bernstein et al.
  Inhalation Toxicology
Schneider F, Sporn TA, Roggli VL. 2010. Asbestos fiber content of lungs 
with diffuse interstitial fibrosis: An analytical scanning electron 
microscopic analysis of 249 cases. Arch Pathol Lab Med 134:457–
461.2nd edn. Hodder Education: Hachette UK Company, London.
Shetty S, John J, Idell S. 2008. In Light RW, Arnold H (eds). Pleural 
Fibrosis. In Textbook of Pleural Diseases. 
Speil S, Leineweber JP. 1969. Asbestos minerals in modern technology. 
Environ Res 2:166–208.
Stoeber W, Flachsbart H, Hochrainer D. 1970. Der aerodynamische 
durchmesser von latexaggregaten und asbestfassern. Staub-Reinh 
Luft 30:277–285.
Wypych  F,  Adad  LB,  Mattoso  N,  Marangon  AA,  Schreiner  WH. 
2005.  Synthesis  and  characterization  of  disordered  layered 
silica obtained by selective leaching of octahedral sheets from 
chrysotile  and  phlogopite  structures.  J  Colloid  Interface  Sci 
283:107–112.
Zeidler-Erdely  PC,  Calhoun  WJ,  Ameredes  BT,  Clark  MP,  Deye  GJ, 
Baron P, Jones W, Blake T, Castranova V. 2006. In vitro cytotoxicity 
of Manville Code 100 glass fibers: effect of fiber length on human 
alveolar macrophages. Part Fibre Toxicol 3:5.
Zocchi  L.  2002.  Physiology  and  pathophysiology  of  pleural  fluid 
turnover. Eur Respir J 20:1545–155.